Research News

Genetic marker may help target aspirin for colorectal cancer

BMJ 2012; 345 doi: (Published 30 October 2012) Cite this as: BMJ 2012;345:e7281

OpenUrlCrossRefMedlineWeb of Science

Researchers from the US have found a link between the use of aspirin and better survival in adults with a genetically distinct type of colorectal cancer. Among 161 men and women whose cancers had a mutation in the PIK3CA gene, use …

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial